Hilltop Holdings Inc. lifted its position in CVS Health Corp (NYSE:CVS) by 258.2% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 34,047 shares of the pharmacy operator’s stock after acquiring an additional 24,542 shares during the quarter. Hilltop Holdings Inc.’s holdings in CVS Health were worth $1,855,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently modified their holdings of the company. Executive Wealth Management LLC lifted its holdings in shares of CVS Health by 62.4% in the 2nd quarter. Executive Wealth Management LLC now owns 565 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 217 shares during the last quarter. Manchester Financial Inc. bought a new stake in CVS Health during the 2nd quarter valued at $31,000. Hudock Capital Group LLC raised its stake in CVS Health by 54.0% during the 2nd quarter. Hudock Capital Group LLC now owns 576 shares of the pharmacy operator’s stock valued at $31,000 after acquiring an additional 202 shares in the last quarter. Tarbox Family Office Inc. raised its stake in CVS Health by 74.7% during the 2nd quarter. Tarbox Family Office Inc. now owns 580 shares of the pharmacy operator’s stock valued at $32,000 after acquiring an additional 248 shares in the last quarter. Finally, C J Advisory Inc bought a new stake in CVS Health during the 1st quarter valued at $33,000. Institutional investors own 75.89% of the company’s stock.
Shares of NYSE CVS opened at $64.31 on Friday. The company has a quick ratio of 0.64, a current ratio of 0.95 and a debt-to-equity ratio of 1.39. The stock has a market capitalization of $82.56 billion, a price-to-earnings ratio of 9.08, a PEG ratio of 1.39 and a beta of 0.85. The stock’s fifty day simple moving average is $60.37 and its 200 day simple moving average is $55.98. CVS Health Corp has a 52-week low of $51.72 and a 52-week high of $82.15.
CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, August 7th. The pharmacy operator reported $1.89 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.70 by $0.19. The business had revenue of $63.43 billion for the quarter, compared to analysts’ expectations of $62.66 billion. CVS Health had a return on equity of 16.15% and a net margin of 1.91%. The company’s quarterly revenue was up 35.2% on a year-over-year basis. During the same period in the previous year, the firm posted $1.69 EPS. As a group, analysts anticipate that CVS Health Corp will post 6.96 earnings per share for the current year.
Several analysts have weighed in on CVS shares. Cowen reaffirmed an “outperform” rating and set a $76.00 target price (up previously from $69.00) on shares of CVS Health in a research note on Tuesday, August 27th. ValuEngine downgraded CVS Health from a “sell” rating to a “strong sell” rating in a research note on Tuesday, July 2nd. Mizuho set a $71.00 target price on CVS Health and gave the company a “buy” rating in a research note on Wednesday, June 5th. Deutsche Bank assumed coverage on CVS Health in a research note on Thursday, September 12th. They set a “buy” rating and a $91.00 target price on the stock. Finally, Citigroup lifted their price target on CVS Health from $68.00 to $72.00 and gave the company a “buy” rating in a research report on Thursday, August 8th. Two analysts have rated the stock with a sell rating, seven have issued a hold rating, eighteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $75.91.
In related news, CFO Eva C. Boratto sold 8,130 shares of CVS Health stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $65.00, for a total value of $528,450.00. Following the transaction, the chief financial officer now directly owns 55,273 shares in the company, valued at approximately $3,592,745. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.53% of the company’s stock.
CVS Health Profile
CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.
Further Reading: What is the G-20?
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.